--- title: "ETNB.US (ETNB.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ETNB.US/news.md" symbol: "ETNB.US" name: "ETNB.US" parent: "https://longbridge.com/en/quote/ETNB.US.md" datetime: "2026-05-20T14:50:11.408Z" locales: - [en](https://longbridge.com/en/quote/ETNB.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ETNB.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ETNB.US/news.md) --- # ETNB.US (ETNB.US) — Related News ### [4basebio Leases New Cambridge Facility to Scale Synthetic DNA Manufacturing](https://longbridge.com/en/news/281150067.md) *2026-03-31T08:22:23.000Z* > 4basebio Leases New Cambridge Facility to Scale Synthetic DNA Manufacturing ### [Over $11.7 billion enters the game! The heat in this sector is off the charts](https://longbridge.com/en/news/268526548.md) *2025-12-04T03:10:19.000Z* > Recently, pharmaceutical giants have been acquiring FGF21 analogs at high prices. Novo Nordisk AS acquired Akero Therape ### [Top Pharmaceutical Stocks To Add to Your Watchlist - November 6th](https://longbridge.com/en/news/264709377.md) *2025-11-06T19:11:43.000Z* > Eli Lilly, Pfizer, Novo Nordisk, 89BIO, McKesson, AbbVie, and Teva Pharmaceutical Industries are highlighted as top phar ### [Promising Pharmaceutical Stocks Worth Watching - November 4th](https://longbridge.com/en/news/264275711.md) *2025-11-04T19:12:50.000Z* > Eli Lilly, Pfizer, Novo Nordisk, 89BIO, and Metsera are highlighted as promising pharmaceutical stocks to watch, accordi ### [89BIO (NASDAQ:ETNB) Receives "Overweight" Rating from Cantor Fitzgerald](https://longbridge.com/en/news/263858362.md) *2025-11-01T14:02:59.000Z* > Cantor Fitzgerald has reiterated an "overweight" rating on 89BIO (NASDAQ:ETNB) shares. Other analysts have mixed views, ### [Cantor Fitzgerald Remains a Buy on 89bio (ETNB)](https://longbridge.com/en/news/263776448.md) *2025-10-31T14:57:56.000Z* > According to TipRanks, Seedhouse is a 4-star analyst with an average return of 11.5% and a 44.69% success rate. Seedhous ### [89bio Completes Merger and Delists from Nasdaq](https://longbridge.com/en/news/263536300.md) *2025-10-30T13:34:15.000Z* > 89bio has completed its merger, resulting in its delisting from Nasdaq and significant changes in its management structu ### [89bio, Inc. Announces Board and Officer Changes Following Merger](https://longbridge.com/en/news/263528018.md) *2025-10-30T13:05:00.000Z* > On October 27, 2025, 89bio, Inc. announced changes to its board and executive team following a merger. Dara Pincas and R ### [Roche purchases shares in tender offer for 89bio, Inc](https://longbridge.com/en/news/263440706.md) *2025-10-30T07:03:00.000Z* > Basel, 30 October 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today that Roche's wholly owned subsidiary Bluef